Supply of Denosumab
Original notice title
Suministro de Denosumab (DOE)
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
45 / 100
Risk factors
The structured lot data contains 28 entries but only two have identifiers and descriptions. This inconsistency may lead...
Selection criteria 'Otros requisitos económicos o financieros' and 'Referencias sobre servicios específicos' are not qu...
Submission deadline in 12 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 505.4k estimated value
- Supplies contract
- 3 lots
- Duration 1 YEAR
- Supply of pharmaceutical product Denosumab in two forms: vial and pre-filled syringe.
- Contract duration 1 year.
Show full summary
Suministro de Denosumab (DOE) - open procedure for supply of Denosumab products to Osakidetza (Basque Health Service) in Spain. Two defined lots: vial and pre-filled syringe. Overall estimated value 505,440 EUR. Electronic submission required, primarily in Spanish and Basque. Award based 55% on price and 45% on quality criteria. Deadline 2026-07-06.
Risks
The structured lot data contains 28 entries but only two have identifiers and descriptions. This inconsistency may lead...
Selection criteria 'Otros requisitos económicos o financieros' and 'Referencias sobre servicios específicos' are not qu...
Submission deadline in 12 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Technical capacity: not specified beyond references.
Eligibility
- Eligibility: economic/financial requirements and references for specific services.
Administrative
- Submission: electronic, via Open portal
Award Criteria
Lot 1
Lot 2
Buyer
Name
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Location
Vitoria-Gasteiz, ESP
Website
Buyer profile
Identifier
S5100023J
Lots (3)
LOT-0001
1 - L1_Denosumab (DOE) vial
Supply of Denosumab in vial form. CPV 33600000. Duration 1 year. Place of performance: ES211 (Álava).
Location
Duration
Category
Selection criteria
Deadline
Award details
Show original TED data
Original TED description
L1_Denosumab (DOE) vial
LOT-0002
2 - L2_Denosumab (DOE) jeringa precargada
Supply of Denosumab in pre-filled syringe form. CPV 33600000. Duration 1 year. Place of performance: ES211 (Álava).
Location
Duration
Category
Selection criteria
Deadline
Award details
Show original TED data
Original TED description
L2_Denosumab (DOE) jeringa precargada
Lot 3
Lot 3
Incomplete lot data - no identifier or title provided.
Procurement Details
- Publication date
- 07 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Spanish, Eus
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 391178-2026
- Source notice ID
- 715ea344-f3a0-4679-a7cc-d4550dace630
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
45 / 100
Risk factors
The structured lot data contains 28 entries but only two have identifiers and descriptions. This inconsistency may lead...
Selection criteria 'Otros requisitos económicos o financieros' and 'Referencias sobre servicios específicos' are not qu...
Submission deadline in 12 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications